To expand high-performance biopolymer applications to additional markets
To apply the biotransformation technology to the local brands and packaging companies
To a newly-formed investment of Arsenal Capital Partners
To bring new Biotransformation technology to market in South East Asia
At its Cuddalore plant in India
Total consideration of approx. CHF 308 million
After closing, SABIC becomes Clariant’s largest strategic anchor shareholder
The PBITDA for the quarter ended June 30, 2018, stood at Rs. 24.81 crore
Acquires stakes previously held by 40 North and Corvex Management
Strategically located with easy access to raw materials and good logistical connections